Ligand validation:7MA1

065: (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(2S,3R)-3-HYDROXY-4-(N-ISOBUTYLBENZO[D][1,3]DIOXOLE-5-SULFONAMIDO)-1-PHENYLBUTAN-2-YLCARBAMATE

065 is a Ligand Of Interest in 7MA1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7MA1_065_A_107	82%	3%	0.109	0.965	4.78	1.63	31	8	0	0	100%	1
2QD7_065_B_404	99%	43%	0.061	0.988	0.99	1.22	2	7	1	0	100%	1
2QCI_065_B_404	91%	38%	0.088	0.974	1.42	1.02	3	3	1	0	100%	0.62
2QD6_065_B_404	90%	35%	0.082	0.965	1.42	1.13	4	4	0	0	100%	0.57
2QD8_065_B_404	90%	42%	0.088	0.969	1.17	1.09	3	2	0	0	100%	0.62
2Z4O_065_B_404	84%	30%	0.105	0.968	1.47	1.32	5	9	1	0	100%	0.6
3ECG_065_A_201	88%	24%	0.087	0.964	1.44	1.64	7	13	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.